Product Description
The global orthopedic cell therapy market was valued at $551.3 million in 2024. This is expected to increase over the forecast period at a CAGR of 7.2% to reach $895.8 million.
The full report suite on the global market for orthopedic cell therapy includes platelet-rich cell therapy and bone marrow cell therapy.
This report includes data for 65 countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2021
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL ORTHOPEDIC CELL THERAPY MARKET INSIGHTS
The cell therapy market experienced a notable decline in sales due to the COVID-19 pandemic. The primary driver was the widespread cancellation and postponement of elective surgeries, which significantly disrupted the industry’s ecosystem. While this downturn was temporary, the impact in 2020 was substantial, with many companies incurring unprecedented losses. However, the market demonstrated resilience and managed to recover notably by 2022, returning to its trajectory of steady growth.
GLOBAL ORTHOPEDIC CELL THERAPY MARKET SHARE INSIGHTS
- Terumo was the leader of the orthopedic cell therapy market for 2024. Harvest Technologies products include Harvest® BMAC and Harvest® PRP. Harvest Technologies also has an adipose tissue concentrator, Harvest® AdiPrep®, and its Harvest® SmartPrep multicellular processing system, which is capable of handling bone marrow, blood and adipose tissue for concentration.
- Zimmer Biomet held the second-leading position in the orthopedic cell therapy market by offering the Plasmax®Plasma concentration and decompression system and its BioCUE™ System, which is capable of handling both bone marrow and whole blood.
- Arthrex was the third-leading competitor in the orthopedic cell therapy market in 2024. One of their primary products is the Arthrex Angel® cPRP and Bone Marrow Processing System, a versatile device designed to concentrate platelet-rich plasma (PRP) and bone marrow aspirate (BMA) for therapeutic use, especially in orthopedic and soft tissue treatments. This system is known for its advanced sensor technology, which automates the separation and concentration of blood components to prepare PRP and BMA efficiently and with minimal manual handling.
GLOBAL ORTHOPEDIC CELL THERAPY MARKET SEGMENTATION SUMMARY
- Platelet-rich Cell Therapy Market – Further Segmented Into:
- Indication Type: Soft Tissue, Spine, Cardiac, Orthopedic, and Plastics.
- Bone Marrow Cell Therapy Market – Further Segmented Into:
- Indication Type: Soft Tissue, Spine, Trauma, and Joint Reconstructions.
GLOBAL RESEARCH SCOPE
Report Attribute | Details |
---|---|
Regions | North America(Canada, United States) Latin America(Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe(Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East(Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific(Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa(Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2024 |
Forecast | 2025-2031 |
Historical Data | 2021-2023 |
Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |